Cargando…

Direct and indirect anti-leukemic properties of activity-on-target interferons for the treatment of T-cell acute lymphoblastic leukemia

Detalles Bibliográficos
Autores principales:	Goossens, Steven, Cauwels, Anje, Pieters, Tim, De Smedt, Renate, T’Sas, Sara, Almeida, André, Daneels, Willem, Van Vlierberghe, Pieter, Tavernier, Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152961/ https://www.ncbi.nlm.nih.gov/pubmed/34647441 http://dx.doi.org/10.3324/haematol.2021.278913

Ejemplares similares

Myb drives B-cell neoplasms and myeloid malignancies in vivo
por: Pieters, Tim, et al.
Publicado: (2022)

ZEB2 and LMO2 drive immature T-cell lymphoblastic leukemia via distinct oncogenic mechanisms
por: Goossens, Steven, et al.
Publicado: (2019)

Overcoming Steroid Resistance in T Cell Acute Lymphoblastic Leukemia
por: Goossens, Steven, et al.
Publicado: (2016)

Controlling Pre-leukemic Thymocyte Self-Renewal
por: Goossens, Steven, et al.
Publicado: (2014)

Pre-Clinical Evaluation of the Hypomethylating Agent Decitabine for the Treatment of T-Cell Lymphoblastic Lymphoma
por: Provez, Lien, et al.
Publicado: (2023)

Tolerizing Strategies for the Treatment of Autoimmune Diseases: From ex vivo to in vivo Strategies
por: Cauwels, Anje, et al.
Publicado: (2020)

P320: A NOVEL MAMMALIAN L-ASPARAGINASE WITH NO L-GLUTAMINASE ACTIVITY IS HIGHLY EFFICACIOUS AGAINST T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN VIVO
por: Van Trimpont, Maaike, et al.
Publicado: (2023)

The effect of resveratrol on the expression of MDR1 gene in leukemic lymphoblast’s of acute lymphoblastic leukemia patients
por: Hosein poor Feyzi, Abbas Ali, et al.
Publicado: (2015)

Novel strategy for rapid functional in vivo validation of oncogenic drivers in haematological malignancies
por: Pieters, Tim, et al.
Publicado: (2019)

Cyclin D2 overexpression drives B1a-derived MCL-like lymphoma in mice
por: Pieters, Tim, et al.
Publicado: (2021)

Bilateral Leukemic Pulmonary Infiltrates: An Initial Presentation of Acute Lymphoblastic Leukemia Relapse
por: Taneja, Kushagra, et al.
Publicado: (2021)

Targeting Leukemia-Initiating Cells and Leukemic Niches: The Next Therapy Station for T-Cell Acute Lymphoblastic Leukemia?
por: Zhang, Ziting, et al.
Publicado: (2022)

Deregulation of linc-PINT in acute lymphoblastic leukemia is implicated in abnormal proliferation of leukemic cells
por: Garitano-Trojaola, Andoni, et al.
Publicado: (2018)

S239: SOX11 DRIVES B1A LINEAGE COMMITMENT AND B1A/MCL-LIKE LYMPHOMA FORMATION IN MICE
por: Pieters, Tim, et al.
Publicado: (2023)

NF-κB in T-cell Acute Lymphoblastic Leukemia: Oncogenic Functions in Leukemic and in Microenvironmental Cells
por: dos Santos, Nuno R., et al.
Publicado: (2010)

Comprehensive miRNA expression profiling in human T-cell acute lymphoblastic leukemia by small RNA-sequencing
por: Wallaert, Annelynn, et al.
Publicado: (2017)

Pitavastatin Is Anti-Leukemic in a Bone Marrow Microenvironment Model of B-Lineage Acute Lymphoblastic Leukemia
por: Piktel, Debbie, et al.
Publicado: (2022)

Emerging Epigenetic and Posttranslational Mechanisms Controlling Resistance to Glucocorticoids in Acute Lymphoblastic Leukemia
por: Borin, Cristina, et al.
Publicado: (2023)

Inhibitory Effects of Omacetaxine on Leukemic Stem Cells and BCR-ABL-Induced Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia in Mice
por: Chen, Yaoyu, et al.
Publicado: (2009)

Indirect comparison of tisagenlecleucel and blinatumomab in pediatric relapsed/refractory acute lymphoblastic leukemia
por: Verneris, Michael R., et al.
Publicado: (2021)

Cytotoxic Effects of Vitamin A in Combination with Vincristine, Daunorubicin and 6‐Thioguanine upon Cells from Lymphoblastic Leukemic Patients
por: Pieters, Rob, et al.
Publicado: (1991)

Sulfonoquinovosyl diacylglyceride selectively targets acute lymphoblastic leukemia cells and exerts potent anti-leukemic effects in vivo
por: Jain, Chetan Kumar, et al.
Publicado: (2015)

Unilateral leukemic infiltration and acute angle closure as the first sign of B-cell acute lymphoblastic leukemia relapse
por: Silva, Diana, et al.
Publicado: (2019)

Toward Therapeutic Targeting of Bone Marrow Leukemic Niche Protective Signals in B-Cell Acute Lymphoblastic Leukemia
por: Delahaye, Marjorie C., et al.
Publicado: (2021)

Anti-Leukemic Effects of Idesia polycarpa Maxim Branch on Human B-Cell Acute Lymphoblastic Leukemia Cells
por: Kwon, Chan-Seong, et al.
Publicado: (2023)

The Soluble Guanylate Cyclase Activator BAY 58-2667 Protects against Morbidity and Mortality in Endotoxic Shock by Recoupling Organ Systems
por: Vandendriessche, Benjamin, et al.
Publicado: (2013)

The soluble guanylate cyclase activator BAY 58-2667 protects against morbidity and mortality in endotoxic shock by recoupling organ systems
por: Vandendriessche, Benjamin, et al.
Publicado: (2013)

PHF6 mutations in T-cell acute lymphoblastic leukemia
por: Van Vlierberghe, Pieter, et al.
Publicado: (2010)

Reactive oxygen species and small-conductance calcium-dependent potassium channels are key mediators of inflammation-induced hypotension and shock
por: Cauwels, Anje, et al.
Publicado: (2010)

Phosphatase of regenerating liver-3 is expressed in acute lymphoblastic leukemia and mediates leukemic cell adhesion, migration and drug resistance
por: Hjort, Magnus A., et al.
Publicado: (2017)

The lncRNA TEX41 is upregulated in pediatric B-Cells Acute Lymphoblastic Leukemia and it is necessary for leukemic cell growth
por: Orlandella, Francesca Maria, et al.
Publicado: (2021)

ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?
por: Soen, Bieke, et al.
Publicado: (2018)

SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival
por: Su, Hexiu, et al.
Publicado: (2018)

An Aggregated-Based Deep Learning Method for Leukemic B-lymphoblast Classification
por: Kasani, Payam Hosseinzadeh, et al.
Publicado: (2020)

Expression Patterns of Coagulation Factor XIII Subunit A on Leukemic Lymphoblasts Correlate with Clinical Outcome and Genetic Subtypes in Childhood B-cell Progenitor Acute Lymphoblastic Leukemia
por: Kárai, Bettina, et al.
Publicado: (2020)

Three-dimensional chromatin landscapes in T cell acute lymphoblastic leukemia
por: Kloetgen, Andreas, et al.
Publicado: (2020)

Indirect Treatment Comparison of Inotuzumab Ozogamicin Versus Blinatumomab for Relapsed or Refractory Acute Lymphoblastic Leukemia
por: Proskorovsky, Irina, et al.
Publicado: (2019)

Characterization of activating mutations of NOTCH3 in T cell acute lymphoblastic leukemia and anti-leukemic activity of NOTCH3 inhibitory antibodies
por: Bernasconi-Elias, Paula, et al.
Publicado: (2016)

The photosensitizer verteporfin has light-independent anti-leukemic activity for Ph-positive acute lymphoblastic leukemia and synergistically works with dasatinib
por: Morishita, Takanobu, et al.
Publicado: (2016)

Dominant T-cell Receptor Delta Rearrangements in B-cell Precursor Acute Lymphoblastic Leukemia: Leukemic Markers or Physiological γδ T Repertoire?
por: Kelm, Miriam, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1bon70ej1ejtlibvkhaudcfm12